IDT offers rival bid to make 100 millions MRNA vaccines, page-123

First 123 Last

Share
Profile

Follow
aflyingfish

546 Posts.

108

26/08/21

16:11

Post #: 55599037
Share

Originally posted by Batmansdaughter: ↑

IDT investors

especially newbies to the trading game. Are you wondering why the price is falling slightly and not 'rocketing' when the company is about to become an mRNA vaccine developer in Australia? Why isn't the big money buying it up to capitalize on these early day low prices etc?

Before I say anymore, we all know that IDT may become a very good investment and the big money may certainly enter. I too have made my modest entry buy.

But big brass has their reasons. If they were buying now, the price would be pushing much further than the measely 160m MC.

So why aren't they?

The answer is quite simple. It is not a sure thing yet, and big money doesn't flow until surety is secured - as far as it can be in stock trading. Speculation money will push it around a little, as it has done so far, but real gains won't occur until real money appears.

It is not a sure thing yet as their are other horses in the running, and it is in the reigns of politicians. Say no more.

Have you done your DD; have you read things like the following;

“The Thebarton facility, according to both Wisenberg and Anton Middelberg, professor of chemical and biomolecular engineering at Adelaide University, is the front-running bacterial cell plant in the country, and the only one with the right skillset and regulations already in place.‘When you look at mRNA vaccines, you actually need to have capacity to make bacterial fermentation work and do that in a regulated facility, and the only regulated facility in Australia at the moment, for bacterial fermentation, is BioCina,’ says Middelberg.”If you havn't loooked into this single competitor, then you havn't done proper DD.

Do you DD before you invest too much. Eventually traders and investors learn that speculative investing requires being prepared for the unexpected. Don't become overly reliant on any 'sure thing' investment.

Expand

Thanks Dad.

IDT Price at posting: 64.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

MYR

Myer combines with Apparel for 'leading retail platform' anticipated to make $30M a year

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 89 more messages in this thread...

First 123 Last

Add IDT (ASX) to my watchlist

(20min delay)
Last 12.5¢		Change -0.005(3.85%)		Mkt cap ! $53.73M

Open	High	Low	Value	Volume
12.5¢	12.8¢	12.5¢	$18.81K	150.5K

Buyers (Bids)

No.	Vol.	Price($)
3	85680	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	338664	3

View Market Depth

No.	Vol.	Price($)
3	85680	0.125
5	308999	0.120
8	785476	0.115
8	438201	0.110
3	409533	0.105

Price($)	Vol.	No.
0.130	338664	3
0.135	60641	3
0.140	90000	3
0.145	114987	3
0.150	290870	5

Last trade - 16.10pm 28/10/2024 (20 minute delay)

IDT (ASX) Chart

IDT offers rival bid to make 100 millions MRNA vaccines, page-123

Myer combines with Apparel for 'leading retail platform' anticipated to make $30M a year

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

IDT offers rival bid to make 100 millions MRNA vaccines, page-123

Top Stories

Myer combines with Apparel for 'leading retail platform' anticipated to make $30M a year

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News